NCT02725606 2017-08-18Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast CancerJiangsu T-Mab Biopharma Co.,LtdPhase 1 Unknown30 enrolled